Jianfan Biotechnology Group Co., Ltd. was founded in 1989, specializing in the research and development, production and sales of biomaterials and high-tech medical devices, and is an A-share GEM-listed company with blood purification products as its main business (stock code: 300529).
Currently, the company is ranked among the top 500 listed companies in China in terms of market capitalization, and ranks at the forefront of China's listed companies in medical devices, and has been awarded the "Golden Bull Most Valuable Investment Prize" for the years of 2017, 2018 and 2019, and the "GEM Listed Company" for the years of 2018, 2019 and 2020, and the "GEM Listed Company" for the years of 2020 and 2020, respectively, It was awarded the "Golden Bull Most Valuable Investment Award" in 2017, 2018 and 2019, and "Top 50 Listed Companies of GEM Board" in 2018, 2019 and 2020, and was honored as "Best Listed Company with Shareholder Returns" and "Competitive Company" in GEM Board of the Finance and Economics Wind and Cloud Ranking in 2019, and was listed on the list of 2020 Hurun China's top 100 health private enterprises, corporate tax payments of more than 300 million yuan.
Jianfan has been awarded the "National Science and Technology Progress Award", "National Torch Program Key High-tech Enterprises", "China Technology Market Association Golden Bridge Award", "Sixth Batch of Manufacturing Individual Item Award" by the Ministry of Industry and Information Technology of the People's Republic of China. "The Sixth Batch of Manufacturing Individual Champion Demonstration Enterprises", the first batch of enterprises in China and the second one in Guangdong Province to pass the GMP inspection of medical devices, selected for the National Industrial Revitalization and Technological Reform Project, the National Major Scientific and Technological Achievement Transformation Project, the Guangdong Strategic Emerging Industries Core Technology Tackling Project, and the National Twelfth Five-Year Plan of Scientific and Technological Support Project. In 2019, the company was selected as the "Benchmark Enterprise of Pharmaceutical Industry for the 70th Anniversary of the Founding of New China". The company's products have passed CE certification and ISO international quality management system certification, and it has been awarded as Guangdong Province Quality Credit Class A medical device manufacturer for ten consecutive years, and it has undertaken two "National Key New Product Projects" and three "National Torch Program Projects". The company has been approved to set up Guangdong Blood Purification Engineering Technology Research and Development Center, Provincial Enterprise Technology Center, Doctoral Research Station, Postdoctoral Research Station and Academician Workstation. The company has strong R&D and production capacity as well as nationwide sales network, and its main products "DNA Immunosorbent Column", "Plasma Bilirubin Adsorber" and "Resin Blood Perfusion Device" have a high market share. "In 2019, Jianfan Biological blood purification machine and blood perfusion machine were selected into the fifth batch of excellent domestic medical equipment products list. The new blood purification research and production base (Jianfan Science and Technology Park) independently invested by the company has been successfully completed and put into production in 2015. In the past two years, the company has set up new markets, scientific research centers and production bases in Beijing and Tianjin, Guangzhou and Shenzhen, Hubei, etc. Together with the existing production bases in Zhuhai Jianfan Science and Technology Park, the company has formed an industrial layout in South China, Central China and North China.
In 2025, Jianfan will create the unique "product-service-finance-'+Internet'" multi-integrated blood purification full-value chain, to realize the group, branding, diversification development, for becoming the To realize the development of groupization, branding and diversification, and to lay a solid foundation for the vision of becoming a "world-class high-tech medical technology enterprise group". We believe that high-tech products + high-quality personnel + high-quality service = success in the near future.